NASDAQ
Lisata Therapeutics, Inc. (LSTA) has a free cash flow growth of 5.11% as of Friday, May 29, 2026. This represents a 20.19% decrease compared to its 12-month average of 6.40%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.